Effects of granulocyte colony-stimulating factor on night sleep in humans

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 276, Issue 4 45-4, 1999, Pages

  Schuld, A ^a   Mullington, J ^a   Hermann, D ^a   Hinze Selch, D ^a   Fenzel, T ^a   Holsboer, F ^a   Pollmacher T ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Interleukin 1 receptor antagonist; Interleukin 1 ; Non rapid eye movement sleep; Soluble tumor necrosis factor receptors; Tumor necrosis factor

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH HORMONE; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BLOOD CELL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELTA RHYTHM; GROWTH HORMONE BLOOD LEVEL; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; IMMUNOMODULATION; MALE; NIGHT SLEEP; NONREM SLEEP; NORMAL HUMAN; PRIORITY JOURNAL; RECTUM TEMPERATURE; SLOW WAVE SLEEP;

EID: 0032958952     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.276.4.r1149     Document Type: Article

References (39)

1. Anderlini, P., D. Przepiorka, B. Champlin, and M. Körbling. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 88: 2819-2825, 1996.
2. Burrell, R. Human responses to bacterial endotoxin. Circ. Shock 43: 137-153, 1994.
3. Fang, J., Y. Wang, and J. M. Krueger. Mice lacking the TNF 55 kDa receptor fail to sleep more after TNF-α treatment. J. Neurosci. 17: 5949-5955, 1997.
4. Friess, E., K. Wiedemann, A. Steiger, and F. Holsboer. The hypothalamic-pituitary-adrenocortical system and sleep in man. Adv. Neuroimmunol. 5: 111-125, 1995.
5. Granowitz, E. V., R. Porat, J. W. Mier, J. P. Pribble, D. M. Stiles, D. C. Bloedow, M. A. Catalano, S. M. Wolff, and C. A. Dianarello. Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 4: 353-360, 1992.
6. Gutierrez, E. G., W. A. Banks, and A. J. Kastin. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47: 169-176, 1993.
7. Gutierrez, E. G., W. A. Banks, and A. J. Kastin. Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier. J. Neuroimmunol. 55: 153-160, 1994.
8. Hinze-Selch, D., J. Mullington, A. Orth, C. J. Lauer, and T. Pollmächer. Effects of clozapine on sleep: a longitudinal study. Biol. Psychiatry 42: 260-266, 1997.
9. Home, J. A., and L. H. E. Staff. Exercise and sleep: body heating effects. Sleep 6: 36-46, 1983.
10. Imeri, L., M. R. Opp, and J. M. Krueger. An IL-1 receptor and an IL-1 receptor antagonist attenuate muramyl dipeptide- and IL-1-induced sleep and fever. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R907-R913, 1993.
11. Jacobson, J. M., J. S. Greenspan, J. Spritzler, N. Ketter, J. L. Fahey, J. B. Jackson, L. Fox, M. Chernoff, A. W. Wu, L. A. McPhail, G. J. Vasquez, and D. A. Wohl. Thalidomide for the treatment of oral aphtous ulcers in patients with human immunodeficiency virus infection. N. Engl. J. Med. 336: 1487-1493, 1997.
12. Kapás L., L. Hong, A. B. Cady, M. R. Opp, A. E. Postlethwaite, J. M. Seyer, and J. M. Krueger. Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-α and TNF-α fragments. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R708-R715, 1992.
13. Karacan I., S. M. Wolff, R. L. Williams, C. J. Hursch, and W. B. Webb. The effects of fever on sleep and dream patterns. Psychosomatics 9: 331-339, 1968.
14. Kimura, M., T. Kodama, M. C. Aguila, S. Q. Zhang, and S. Inoue. REM sleep-inducing cytokines: colony-stimulating factors (Abstract). J. Sleep Res. 7, Suppl. 2: 135, 1998.
15. Kluger, M. J. Fever: role of pyrogens and cryogens. Physiol. Rev. 71: 93-117, 1991.
16. Korth, C., J. Mullington, W. Schreiber, and T. Pollmächer. Influence of endotoxin on daytime sleep in humans. Infect. Immun. 64: 1110-1115, 1996.
17. Krueger, J. M., S. Takahashi, L. Kapás, S. Bredow, R. Roky, J. Fang, R. Floyd, K. B. Renegar, N. Guha-Thakurta, S. Novitsky, and F. Obal. Cytokines in sleep regulation. Adv. Neuroimmunol. 5: 171-188, 1995.
18. Krueger, J. M., J. Walter, C. A. Dinarello, S. M. Wolff, and L. Chedid. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am. J. Physiol. 246 (Regulatory Integrative Comp. Physiol. 15): R994-R999, 1984.
19. Lancel, M., S. Mathias, T. Schiffelholz, C. Behl, and F. Holsboer. Soluble TNF receptor (p75) does not attenuate the sleep changes induced by lipopolysaccharide in the rat during the dark period. Brain Res. 770: 184-191, 1997.
20. Moreira, A. L., E. P. Sampaio, A. Zmuidzinas, P. Frindt, K. A. Smith, and G. Kaplan. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med. 177: 1675-1680, 1993.
21. Mullington, J., D. Hermann, F. Holsboer, and T. Pollmächer. Slow wave sleep and delta power are increased in healthy men following a sub-pyrogenic dose of endotoxin (Abstract). J. Sleep Res. 5, Suppl. 1: 151, 1996.
22. Opp, M. R., and J. M. Krueger. Anti-interleukin-1β reduces sleep and sleep rebound after sleep deprivation in rats. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R688-R695, 1994.
23. Pollmächer, T., D. Hinze-Selch, and J. Mullington. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J. Clin. Psychopharmacol. 16: 403-409, 1996.
24. Pollmächer, T., C. Korth, J. Mullington, W. Schreiber, J. Sauer, H. Vedder, C. Galanos, and F. Holsboer. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 87: 900-905, 1996.
25. Pollmächer, T., W. Schreiber, S. Gudewill, H. Vedder, K. Fassbender, K. Wiedemann, L. Trachsel, C. Galanos, and F. Holsboer. Influence of endotoxin on nocturnal sleep in humans. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R1077-R1083, 1993.
26. Rechtschaffen, A., and A. Kales. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Bethesda, MD: National Institute of Neurological Diseases and Blindness, 1968.
27. Rothwell, N. J., and S. J. Hopkins. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 18: 130-136, 1995.
28. Shoham, S., D. Davenne, A. B. Cady, C. A. Dinarello, and J. M. Krueger. Recombinant tumor necrosis factor and interleukin-1 enhance slow wave sleep. Am. J. Physiol. 253 (Regulatory Integrative Comp. Physiol. 22): R142-R149, 1987.
29. Späth-Schwalbe, E., K. Hansen, F. Schmidt, H. Schrezenmeier, L. Marshall, K. Burger, H. L. Fehm, and J. Born. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J. Clin. Endocrinol. Metab. 83: 1573-1579, 1998.
30. Steiger, A., J. Guldner, U. Hemmeter, B. Rothe, K. Wiedemann, and F. Holsboer. Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 56: 566-573, 1992.
31. Steward, W. P. Granulocyte and granulocyte-macrophage colony-stimulating factors. Lancet 342: 153-157, 1993.
32. Takahashi, S., D. D. Tooley, L. Kapas, J. Fang, J. M. Seyer, and J. M. Krueger. Inhibition of tumor necrosis factor in the brain suppresses rabbit sleep. Pflügers Arch. 431: 155-160, 1995.
33. Tobler, I., A. A. Borbely, M. Schwyzer, and A. Fontana. Interleukin-1 derived from astrocytes enhances slow wave activity in sleep EEG of the rat. Eur. J. Pharmacol. 104: 191-192, 1984.
34. Toth, L. A. Sleep, sleep deprivation and infectious disease: studies in animals. Adv. Neuroimmunol. 5: 79-92, 1995.
35. Trachsel, L. Hartley transforms and narrow bessel bandpass filters produce similar power spectra of multiple frequency oscillators and all-night EEG. Sleep 16: 586-594, 1993.
36. Turnbull, A. V., and C. Rivier. Regulation of the HPA axis by cytokines. Brain Behav. Immun. 9: 253-275, 1995.
37. Wetter, T. C., C. J. Lauer, G. Gillich, and T. Pollmächer. The electroencephalo-graphic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs. J. Psychiatr. Res. 30: 411-419, 1996.
38. Wolkenstein, P., J. Latarjet, J.-C. Roujeau, C. Duguet, S. Boudeau, L. Vaillant, M. Maignan, M.-H. Schuhmacher, B. Milpied, A. Pilorget, and H. Bocquet. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 352: 1586-1589, 1998.
39. Zwingenberger, K., and S. Wnendt. Immunomodulation by thalidomide: systematic review of the literature and of unpublished observations. J. Inflamm. 46: 177-211, 1996.